Helicobacter Pylori is the Cause of Gastric Cancer by Barukčić, Ilija
 Modern Health Science; Vol. 1, No. 1; 2018 
ISSN 2576-7291   E-ISSN 2576-7305 
https://doi.org/10.30560/mhs.v1n1p43 
 43 Published by IDEAS SPREAD 
 
Helicobacter Pylori is the Cause of Gastric Cancer 
Ilija Barukčić1 
1 Internist, Horandstrasse, DE-26441 Jever, Germany 
Correspondence: Ilija Barukčić, Horandstrasse, DE-26441 Jever, Germany. Tel: 49-4466-333. E-mail: 
Barukcic@t-online.de 
 
Received: May 21, 2018; Accepted: June 13, 2018; Published: June 22, 2018 
 
Abstract 
Objective: This study presents a systematic meta-analysis of the relationship between Helicobacter pylori (HP) 
infection and gastric cancer (GC).  
Materials and Methods: Twelve articles including 21589 subjects were selected (1237 cases and 20352 controls). 
These data were analyzed using the mathematical formula of the conditio sine qua non relationship and the causal 
relationship formula. 
Results: The data re-analyzed support the Null hypothesis without a Helicobacter pylori infection no human gastric 
cancer. The causal relationship between HP and GC is highly significant. 
Conclusion: Helicobacter pylori is the cause of human gastric cancer. 
Keywords: Helicobacter pylori, gastric cancer, cause effect relationship, causality 
1. Introduction 
Gastric cancer mortality and incidence decreased substantially over the last decades in most countries worldwide. 
Still, gastric cancer (GC) is among the most common causes of cancer death globally (Ferro et al., 2014) and the 
second leading cause of cancer-related mortality worldwide. Early modern humans migrated (Correa & Piazuelo, 
2012) out of Africa along with the bacterium Helicobacter pylori, its own oldest and closest companion, 
approximately 60,000 years ago. Meanwhile, H. pylori infection affects about 50% of the global (Tobacco Smoke 
and Involuntary Smoking. 2004) population. German scientists (Blaser, 2005) identified spiral-shaped bacteria in 
the human stomach in 1875. Bizzozero (Bizzozero, 1893) an Italian pathologist, described similarly shaped 
bacteria in the stomach of dogs in 1893. H. pylori is a spiral-shaped, gram-negative microaerophilic bacterium 
which has been re-discovered (Buzás, 2004) by Barry J. Marshall and J. Robert Warren (Warren & Marshall, 1983) 
in 1983. The first description of gastric ulceration (Buckley & O'Morain, 1998) was reported in 1586 by an Italian 
physician (Donati, 1586). For a long time, the therapy of gastric ulceration was dominated by the 1910 dictum 'no 
acid, no ulcer' (Schwarz, 1910) of the Croatian physician Karl Schwarz. In particular, several studies (Forman et 
al., 1991; Nomura et al., 1991; Parsonnet et al., 1991; Estevens et al., 1993) reported a higher risk of the 
development of gastric cancer in subjects with positive serologic tests for H. pylori. Finally, the World Health 
Organization and the International Agency for Research on Cancer (IARC Working Group on the Evaluation of 
Carcinogenic Risks to Humans. 1994) classified H pylori as a class 1 carcinogen in 1994. The rates of Helicobacter 
pylori infection in patients with gastric cancer vary greatly among studies. Thus far, most but not all studies, 
systematic reviews and meta-analysis confirmed (Lin et al., 1995) that H. pylori is associated with gastric cancer. 
However, due to conflicting reports (Moss, 2017) in the literature regarding the relationship between H. pylori and 
human gastric cancer Helicobacter pylori is still not accepted as the cause of gastric cancer (Barukčić, 2005; 
Barukčić, 2006; Barukčić, 2006; Barukčić, 2009; Barukčić, 2017; Ando et al., 2006). 
2. Material and Methods 
The rates of Helicobacter pylori infection vary greatly among studies. These variations are attributable to 
differences in the methods of detecting H. pylori (enzyme-linked immunosorbent assay (ELISA), western blot et 
cetera) which are associated with different false negative results or with the definition of cut of values and other 
factors.  
2.1 Search Strategy 
For the questions addressed in this paper, Pubmed was searched for appropriate studies conducted in any country 
which investigated the relationship between Helicobacter pylori and gastric cancer.  
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The search in Pubmed was performed while using medical key words like “Helicobacter pylori” and “gastric 
cancer” and “antibody” and “review” et cetera. The articles found where saved as a *.txt file while using Pubmed 
support (Menu: Send to, Choose Radio Button: File, Choose Format: Abstract (text). Click buttom “create file”). 
The created *.txt file was converted into a *.pdf file. The abstracts where studied within the *.pdf file.  
Those articles were considered for a review which provided access to data without any data access barrier; no data 
access restrictions were accepted. Additionally, references from relevant publications and review articles were 
checked. Studies were included if the same allowed to compare the prevalence of Helicobacter pylori in patients 
with gastric cancer with the prevalence in healthy controls.  
Studies were excluded if insufficient data were provided to calculate the measures of relationship or if there were 
data access barriers.  
2.2 The Data of the Studies Analyzed 
The data of the studies analyzed are presented by the table 1 (Table 1). In point of fact, bias due to the differences 
in the methods used to detect HP and a systemic and substantial under-detection of Helicobacter pylori infection 
and underestimation of its effect on gastric cancer is at the end not excluded. 
 
Table 1. The data of the studies considered for a meta-analysis 
Study Id Year Country N Case Pos Case Tot Contol pos Control Tot 
Forman et al. (Forman et al., 1991) 1991 UK 145 20 29 54 116 
Parsonnet et al. (Nomura et al., 1991) 1991 USA 295 92 109 111 186 
Nomura et al. (Parsonnet et al., 1991) 1991 USA 218 103 109 83 109 
Uemura et al. (Uemura et al., 2001) 2001 Japan 1526 36 36 1210 1490 
Miki (Miki 2011)  2011 Japan 5290 59 63 4151 5227 
González et al. (González et al., 2012) 2012 Spain 476 72 88 188 388 
Keck et al. (Keck et al., 2014) 2014 USA 468 112 122 285 346 
Yoshida et al. (Yoshida et al., 2014) 2014 Japan 4655 81 87 3576 4568 
Sarker et al. (Sarker et al., 2017) 2017 Bangladesh 634 99 114 351 520 
Huerta et al. (Huerta et al., 2017) 2017 Spain 2277 239 257 1777 2020 
Fernández de Larrea-Baz et al.  
(Fernández et al., 2017) 2017 Spain 2284 202 213 1822 2071 
Shuto et al. (Shuto et al., 2017) 2017 Japan 3321 10 10 1881 3311 
  Total 21589 1125 1237 15489 20352 
 
Table 2. The sample space of a contingency table 
  
Conditioned Bt 
(Crohn’s disease) 
 
  Yes = +1 Not = +0 Total 
Condition At  
(HP PCR DNA) 
Yes =+1 at bt At 
Not = +0 ct dt At 
 Total Bt Bt Nt 
 
2.3 Statistical Analysis 
All statistical analyses were performed with Microsoft Excel ® version 14.0.7166.5000 (32-Bit) software 
(Microsoft GmbH, Munich, Germany). All P values are two-sided; significance was indicated by a P value of less 
than 0.05. The following statistical tools and techniques were used to analyze the data. 
2.3.1 The 2x2 Table 
The 2x2 table in this article is defined (Barukčić, 2005; Barukčić, 2006; Barukčić, 2006; Barukčić, 2009; Barukčić, 
2017), (Barukčić, 1989; Barukčić, 1997) in general more precisely (Table 2) as follows. 
In general it is (a+b) = At, (c+d) = At, (a+c) = Bt, (b+d) = Bt and at+bt+ct+dt=Nt. Equally, it is Bt+Bt = At + At = Nt. 
In this context, it is p(at)=p(At Bt), p(At) = p(at)+p(bt) or in other words p(At)= p(At Bt)+p(At Bt) while p(At) 
is not defined as p(at). In the same context, it should be considered that p(Bt) = p(at)+p(ct) = p(At Bt) +p(ct) and 
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equally that p(Bt) = 1- p(Bt) =p(bt)+p(dt). In point of fact, the joint probability of At and Bt is denoted by p(At Bt). 
It is p(at)+p(ct)+p(bt)+p(dt) = 1. These relationships are viewed by the table (Table 3) as follows. 
 
Table 3. The probabilities of a contingency table 
  
Conditioned 
Bt 
 
  Yes = +1 No = +0 Total 
Condition 
At 
Yes =+1 p(at) = p(At Bt) p(bt) p(At) 
No = +0 p(ct) p(dt) p(At) 
 Total p(Bt) p(Bt) 1 
 
2.3.2 Independence 
In the case of independence of At and Bt it is 
(1) 
 
2.3.3 Necessary Condition (Conditio Sine Qua Non) 
The formula of the necessary condition (conditio sine qua non) (Barukčić, 2005; Barukčić, 2006; Barukčić, 2006; 
Barukčić, 2009; Barukčić, 2017), (Barukčić, 1989; Barukčić, 1997) relationship was derived as 
 
(2) 
 
and used to proof the hypothesis: without At (i.e. condition, “risk factor”) no Bt (i. e. conditioned, outcome).  
2.3.4 The X² Goodness of Fit Test of a Necessary Condition 
Under conditions where the chi-square (Pearson, 1900) goodness of fit test cannot be used it is possible to use an 
approximate and conservative (one sided) confidence interval as discussed by Rumke (Rumke, 1975), Louis (Louis, 
1981), Hanley et al. (Hanley & Lippman-Hand, 1983) and Jovanovic (Jovanovic & Levy, 1997) known as the rule 
of three. According to the definition of the conditio sine qua non relationship it is 
 
(3) 
or 
 
(4) 
or 
(5) 
Multiplying equation before by the population or sample size N, it is 
 
(6) 
or 
(7) 
The square operation yields 
 
(8) 
Dividing by Np(Bt) we obtain  
 
(9) 
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which is equivalent with 
 
(10) 
 
 
Adding 0 yields 
 
(11) 
 
Using the continuity correction, the chi-square value of a conditio sine qua non distribution follows as 
 
 
 
(12) 
This definition of the X² distribution of a conditio sine qua non distribution  (degrees of freedom = 2-1=1)  is 
more precise than already published (Barukčić, 2018; Barukčić, 2018; Barukčić, 2018) formulas. The use of the 
continuity correction should follow the rules of statistics as established and valid today. In this context, it is not 
necessary to improve the definition of the X² distribution of a conditio per quam distribution as already published 
(Barukčić, 2018; Barukčić, 2018; Barukčić, 2018).  
2.3.5 The Mathematical Formula of the Causal Relationship k 
The mathematical formula of the causal relationship k (Barukčić, 2005; Barukčić, 2006; Barukčić, 2006; Barukčić, 
2009; Barukčić, 2017), (Barukčić, 1989; Barukčić, 1997) is defined at every single event, at every single Bernoulli 
trial t, as 
 
 
 
(13) 
where RUt denotes the cause and 0Wt denotes the effect while the chi-square distribution (Pearson, 1900) can be 
applied to determine the significance of causal relationship k. Correlation is not causation, causation is not 
correlation. The relationship between correlation and causation is discussed already in many publications (Pearson, 
1900). This does not necessarily imply that repeating itself over and over again may contribute anything new to 
further scientific progress. 
 
Table 4. The critical values of the chi square distribution (degrees of freedom: 1) 
  p-Value One sided X² Two sided X² 
The chi 
square 
distribution 
 
0,1000000000 
0,0500000000 
0,0400000000 
0,0300000000 
0,0200000000 
0,0100000000 
0,0010000000 
0,0001000000 
0,0000100000 
0,0000010000 
0,0000001000 
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0,0000000010 
0,0000000001 
1,642374415 
2,705543454 
3,06490172 
3,537384596 
4,217884588 
5,411894431 
9,549535706 
13,83108362 
18,18929348 
22,59504266 
27,03311129 
31,49455797 
35,97368894 
40,46665791 
2,705543454 
3,841458821 
4,217884588 
4,709292247 
5,411894431 
6,634896601 
10,82756617 
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2.3.6 The Chi Square Distribution 
Evaluating hypotheses in the light of empirical facts is not an easy task. In particular, mathematics and statistics 
provide us with specific methods to relate facts and hypotheses under certain conditions. And there is so much 
more. Interested readers may bear in mind that an entirely different approach and one very important aspect of 
statistics is the conceptual analysis of causal relations too. A general discussion of the justification of inferences 
or procedures which extrapolate from data to predictions and general facts may be found in secondary literature. 
In this context, the chi-squared distribution (Pearson, 1900), a widely known distribution in hypothesis testing, in 
inferential statistics or in construction of confidence intervals, is of use. It can be insightful to consider the 
following critical values of the chi square distribution as visualized by Table 4. 
3. Results 
3.1 Helicobacter Pylori Infection is the Cause of Human Gastric Cancer 
Claims. 
Null hypothesis: 
A Helicobacter pylori infection is a necessary condition (a conditio sine qua non) of human gastric cancer. In other 
words, the sample distribution of the study analyzed agrees with the hypothetical (theoretical) distribution of a 
necessary condition. 
 
Table 5. Without Helicobacter pylori infection no gastric cancer 
Study Id Year Country N at bt ct dt p(SINE) X²(Sine) k p val (k) 
González et al. [] 2012 Spain 476 72 188 16 200 0.9663 2.7301136 0.260153233 1.38E-08 
Parsonnet et al. [] 1991 USA 295 92 111 17 75 0.9423 2.4977064 0.257623841 9.65E-06 
Sarker et al. [] 2017 Bangladesh 634 99 351 15 169 0.9763 1.8442982 0.163660047 3.77E-05 
Nomura et al. [] 1991 USA 218 103 83 6 26 0.9724 0.2775229 0.259237924 0.0001294 
Yoshida et al. [] 2014 Japan 4655 81 3576 6 992 0.99871 0.3477011 0.048902986 0.0008483 
Fernánd. de L.-B. et al. [] 2017 Spain 2284 202 1822 11 249 0.9951 0.5176056 0.062797121 0.0026896 
Uemura et al. [] 2001 Japan 1526 36 1210 0 280 1 0.0069444 0.073684834 0.0039966 
Miki  2011 Japan 5290 59 4151 4 1076 0.9992 0.194444 0.038312294 0.0053273 
Shuto et al. [] 2017 Japan 3321 10 1881 0 1430 1 0.025 0.04779062 0.0058856 
Keck et al. [] 2014 USA 468 112 285 10 61 0.9786 0.739754 0.115440677 0.0125120 
Huerta et al. [] 2017 Spain 2277 239 1777 18 243 0.9920 1.191634 0.049920964 0.0172130 
Forman et al. [] 1991 UK 145 20 54 9 62 0.9379 2.491379 0.179348735 0.0308001 
  Total 21589 1125 15489 112 4863 0.99481 12.86 X² (Calculated k)= 143.776593 
    Alpha = 0.05   Alpha = 0.05 
   Degrees of freedom (D. f.) = 12   D. f. = 12 
    X² (Critical SINE) = 21.0261   X² (Critical k)= 21.0260698 
    X² (Calculated SINE)= 12.8641  X² (Calculated k)= 143.776593 
          p value (k)= 1.03E-24 
 
Alternative hypothesis:  
A Helicobacter pylori infection is not a necessary condition (a conditio sine qua non) of human gastric cancer. In 
other words, the sample distribution of the study analyzed does not agree with the hypothetical (theoretical) 
distribution of a necessary condition. 
The significance level (Alpha) below which the null hypothesis will be rejected is alpha=0,05. 
Proof.  
The results of the re-analyses of the data reviewed by this article (Table 1) which investigated the relationship 
between Helicobacter pylori and gastric cancer are viewed by the table (Table 5). Altogether, 12 studies were meta-
analyzed while the level of significance was alpha = 0,05. In toto, 12 from 12 studies provide significant evidence 
of a conditio sine qua non relationship between Helicobacter pylori and gastric cancer. The sample size was N = 
21589 while the conditio sine qua non probability/relative frequency of the studies analyzed was (21589- 112)/ 
21589= 0.99481. In other words, the data analyzed support the hypothesis without a Helicobacter pylori infection 
no human gastric cancer. In the same respect, 12/12 studies analyzed provided evidence of a significant or highly 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 48 Published by IDEAS SPREAD 
 
significant cause effect relationship between Helicobacter pylori and human gastric cancer. In point of fact, since 
without a Helicobacter pylori infection human gastric cancer will not develop we authorized to draw the following 
conclusion. Helicobacter pylori is the cause of human gastric cancer (k ~ +0,081607078, p-value = 1,03E-24). Q. e. 
d. 
4. Discussion 
Since the re-discovery of Helicobacter pylori the possibility of a relationship with gastric cancer has been tested but 
still not supposedly proven. Numerous different studies of various designs from many countries around the world 
and several meta-analyses (Huang et al., 1998; Rokkas, Rokka & Portincasa, 2017) have been published looking 
at the relationship between H pylori infection and gastric cancer. Over the years, studies have produced conflicting 
results. Gastric cancer remains a major scientific, medical and public health challenge. The exact mechanisms by 
which H pylori might cause gastric cancer is still under investigation and remains to be discovered. H. pylori 
infection varies among regions but besides of all there is emerging evidence that H. pylori is able to raise the risk of 
gastric cancer. Thus far, the findings of this study are consistent with those of several previous studies and meta-
analysis. The prevalence of IgG antibodies to H pylori in blood samples of cases and controls is one way to proof 
the relationship between gastric cancer and helicobacter pylori. The presence of H pylori antibodies does not 
guarantee the presence of H. pylori inside the stomach and is a potential sources of human, systematic and random 
error and bias and can cause the results of a research study to be incorrect. The set of study or experimental data is 
seldom perfect and complete which may threat the validity of the study. In general, researchers even if aware of the 
bias as associated with study design and the data the amount of studies which are reporting the same result is difficult 
to be ignored. Without a Helicobacter pylori infection no human gastric cancer (N=21589, p(SINE)=0.99481, 
X²(Calculated SINE)=12,86 < X² (Critical SINE) = 21,0261, p value (k)= 1,03E-24). This study is of help to further 
reduce the burden of this disease and invites us all to accept the following inescapable conclusion. 
5. Conclusion 
Without a Helicobacter pylori infection no gastric cancer. Helicobacter pylori is the cause of gastric cancer. 
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